TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
KPTI

Karyopharm Therapeutics Inc

Healthcare · Biotechnology

1.80$ +5.3% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Karyopharm Therapeutics Inc (KPTI): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/02/2026.

Next report 11/02/2026
Last report 08/13/2026
Earnings surprise by quarter (%)
Q3 23 · -4.9 % 23 Q4 23 · -16.1 % 23 Q1 24 · 2.8 % 24 Q2 24 · 2.9 % 24 Q3 24 · 0.5 % 24 Q4 24 · 10.7 % 24 Q1 25 · 10.4 % 25 Q2 25 · -4.1 % 25 Q3 25 · -17.5 % 25 Q4 25 · -11.5 % 25 Q1 26 · 13.9 % 26 Q2 26 · -51.6 % 26

EPS estimate beaten

Full history 26 of 51 quarters (51%)
Last 16 quarters 9 of 16 quarters (56%)

Earnings Call Transcripts

Search all transcripts →

  • 08/13/2026 Earnings Call Q2 2026 Open →
  • 05/14/2026 Earnings Call Q1 2026 Open →
  • 02/12/2026 Earnings Call Q4 2025 Open →
  • 11/03/2025 Earnings Call Q3 2025 Open →
  • 08/11/2025 Earnings Call Q2 2025 Open →
  • 05/13/2025 Earnings Call Q1 2025 Open →
  • 02/19/2025 Earnings Call Q4 2024 Open →

News on This Stock

  • 09/11/2026 Karyopharm Therapeutics Inc. (KPTI): Entry into a Material Definitive Agreement; Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement; Unregistered Sales of Equity Securities; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/31/2026 Karyopharm Therapeutics Inc. (KPTI): Other Events · sec.gov Open ↗
  • 08/13/2026 Karyopharm Therapeutics Inc. (KPTI): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/31/2026 Karyopharm Therapeutics Inc. (KPTI): Other Events · sec.gov Open ↗
  • 07/17/2026 Karyopharm Therapeutics Inc. (KPTI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?